Dott. Matteo Armillotta

2019, November – Present Cardiology Medical Resident IRCCS University Hospital Policlinic S. Orsola-Malpighi, Cardiology, Bologna

2019, July – 2019, September Medical Doctor Piccole Figlie Hospital, Parma

• 2023, November – Present PhD in Cardiovascular Science Alma Mater Studiorum, University of Bologna
• 2023, October American Heart Association Advanced Cardiovascular Life Support (ACLS)for Experienced Providers Program
  BIOS, Parma University Hospital – TC
• 2023, March – 2023, October Cardiac Imaging Fellow Centre for Advanced Cardiovascular Imaging, St Bartholomew’s Hospital, London, UK
• 2022, September – 2022, October STEEER-AF educational programme: Stroke prevention and rhythm control Therapy: Evaluation of an Educational Programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation
  European Society of Cardiology
• 2022, May American Heart Association Advanced Cardiovascular Life Support (ACLS) BIOS, Parma University Hospital – TC
• 2021, October American Heart Association Basic Life Support (CPR and AED) BIOS, Parma University Hospital – TC
• 2018, November – 2019, February Professional Qualification in Medicine and Surgery University of Parma
• 2012, October – 2018, July Degree in Medicine and Surgery University of Parma
• 2016, September – 2018, July Internship activities Nephrology Department, Parma University Hospital
• 2017, November CME Course of Diabesity: Renal Disease in Obesity and Diabetes –Advances in Pathogenesis and Therapeutics Lisbon, Portugal, 24/11/2017 – 25/11/2017
• 2017, January – 2017, May Educational Elective Activity (ADE) on diagnosis, management, and therapy of electrolyte and acid base balance University of Parma
• 2007, September – 2012, July High School Leaving Qualification in Scientific Studies Scientific High School “Gian Tommaso Giordani”, Monte Sant’Angelo

• Ciliberti G, Guerra F, Pizzi C, Merlo M, Zilio F, Bianco F, Mancone M, Zaffalon D, Gioscia R, Bergamaschi L, Compagnucci P, Armillotta M, Casella M, Sansonetti A, Marini M, Paolisso P, Stronati G, Gallina S, Dello Russo A, Perna GP, Fedele F, Bonmassari R, De Luca G, Tritto I, Piva T, Sinagra G, Ambrosio G, Kaski JC, Verdoia M. Characteristics of patients with recurrent acute myocardial infarction after MINOCA. Prog Cardiovasc Dis. 2023 Oct 16:S0033-0620(23)00109-3.
• Corianò M, Armillotta M, Battisti NML. Social Determinants of Health and Cardiac Risk for Patients With Breast Cancer: Beyond Racial Disparities. J Natl Compr Canc Netw. 2023 Jul;21(7):783-784.
• Fedele D, Canton L, Bodega F, Suma N, Tattilo FP, Impellizzeri A, Amicone S, Di Iuorio O, Ryabenko K, Armillotta M, Sansonetti A, Stefanizzi A, Cavallo D, Casuso M, Bertolini D, Lovato L, Gallinoro E, Belmonte M, Rinaldi A, Angeli F, Casella G, Foà A, Bergamaschi L, Paolisso P, Pizzi C. Performance of Prognostic Scoring Systems in MINOCA: A Comparison among GRACE, TIMI, HEART, and ACEF Scores. J Clin Med. 2023 Aug 31;12(17):5687.
• Armillotta M, Amicone S, Bergamaschi L, Angeli F, Rinaldi A, Paolisso P, Stefanizzi A, Sansonetti A, Impellizzeri A, Bodega F, Canton L, Suma N, Fedele D, Bertolini D, Foà A, Pizzi C. Predictive value of Killip classification in MINOCA patients. Eur J Intern Med. 2023 Aug 16:S0953-6205(23)00293-5.
• Bergamaschi L, Pavon AG, Angeli F, Tuttolomondo D, Belmonte M, Armillotta M, Sansonetti A, Foà A, Paolisso P, Baggiano A, Mushtaq S, De Zan G, Carriero S, Cramer MJ, Teske AJ, Broekhuizen L, can der Bilt I, Muscogiuri G, Sironi S, Anna Leo L, Gaibazzi N, Lovato L, Pontone G, Pizzi C, Guglielmo M. The Role of Non-Invasive Multimodality Imaging in Chronic Coronary Syndrome: Anatomical and Functional Pathways. Diagnostics. 2023. Accepted, article in press.
• Bergamaschi L, Foà A, Paolisso P, Renzulli M, Angeli F, Frabrizio M, Bartoli L, Armillotta M, Sansonetti A, Stefanizzi A, Rinaldi A, Niro F, Lovato L, Gherbesi E, Carugo S, Pasquale F, Casella G, Galiè N, Rucci P, Bucciarelli-Ducci C, Pizzi C. Prognostic role of early cardiac magnetic resonance in myocardial infarction with non-obstructive coronary arteries (MINOCA). JACC Cardiovasc Imaging.
  2023. Accepted, article in press.
• Armillotta M, Angeli F, Rinaldi A, Bertolini D, Amicone S, Bodega F, Fedele D, Impellizzeri A, Di Iuorio O, Bergamaschi L, Paolisso P, Foà A, Stefanizzi A, Sansonetti A, Canton L, Suma N, Tattilo FP, Cavallo D, Ryabenko K, Casuso Alvarez M, Tortorici G, Pizzi C. Infarto e danno miocardico periprocedurali dopo rivascolarizzazione miocardica: incidenza, implicazioni cliniche e prognosi
  [Periprocedural myocardial injury and infarction after myocardial revascularization: incidence, clinical features and prognosis] G Ital Cardiol (Rome). 2023. Accepted, article in press.
• Paolisso P, Bergamaschi L, Cesaro A, Gallinoro E, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Belmonte M, Esposito G, Morici N, Andrea Oreglia J, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Calabrò P, Barbato E, Marfella R, Pizzi C. Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in Diabetic patients with Acute Myocardial Infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT Registry. Diabetes Res Clin Pract. 2023 Jun 3:110766.
• Canton L, Fedele D, Bergamaschi L, Foà A, Di Iuorio O, Tattilo FP, Rinaldi A, Angeli F, Armillotta M, Sansonetti A, Stefanizzi A, Amicone S, Impellizzeri A, Suma N, Bodega F, Cavallo D, Bertolini D, Ryabenko K, Casuso M, Belmonte M, Gallinoro E, Casella G, Galiè N, Paolisso P, Pizzi C. Sex and age-related differences in outcomes of patients with acute myocardial infarction: MINOCA versus
  MIOCA. Eur Heart J Acute Cardiovasc Care. 2023 Jun 1:zuad059.
• Cavallo D, Armillotta M, Angeli F, Bergamaschi L, Di Iuorio O, Tattilo FP, Ryabenko K, Niro F, Sportoletti C, Lovato L, Foà A, Pizzi C. Unifying Diagnosis Explaining Multiorgan Clinical Manifestations: The Unique Case of Antiphospholipid Syndrome Leading to MINOCA. Circ Cardiovasc Imaging. 2023 May 11:e015371.
• Angeli F, Bergamaschi L, Rinaldi A, Paolisso P, Armillotta M, Stefanizzi A, Sansonetti A, Amicone S, Impellizzeri A, Bodega F, Canton L, Suma N, Fedele D, Bertolini D, Tattilo FP, Cavallo D, Di Iuorio O, Ryabenko K, Casuso Alvarez M, Galiè N, Foà A, Pizzi C. Sex-Related Disparities in Cardiac Masses: Clinical Features and Outcomes. J Clin Med. 2023 Apr 19;12(8):2958.
• Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Nuccia M, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Barbato E, Pizzi C. Reply to SGLT-2 inhibitors: Post-infarction interventional effects. Pharmacol Res. 2023 Jan 13:106664.
• Paolisso P, Foà A, Bergamaschi L, Graziosi M, Rinaldi A, Magnani I, Angeli F, Stefanizzi A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Tattilo FP, Suma N, Bodega F, Canton L, Gherbesi E, Tuttolomondo D, Maietti E, Carugo S, Gaibazzi N, Rucci P, Biagini E, Galiè N, Caldarera I, Pizzi C. Echocardiographic markers in the Diagnosis of Cardiac Masses. J Am Soc Echocardiogr.
  2023 May;36(5):464-473.e2.
• Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Nuccia M, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Pizzi C, Barbato E. Outcomes in Diabetic patients treated with SGLT2-Inhibitors with Acute Myocardial Infarction undergoing PCI: The
  SGLT2-I AMI PROTECT Registry. Pharmacol Res. 2022 Dec 2:106597.
• Paolisso P, Foà A, Magnani I, Bergamaschi L, Graziosi M, Angeli F, Chiti C, Fabrizio M, Rinaldi A, Stefanizzi A, Armillotta M, Sansonetti A, Gallinoro E, Maietti E, Rucci P, Biagini E, Mattioli AV, Galiè N, Pizzi C. Development and Validation of a Diagnostic Echocardiographic Mass Score in the Approach to Cardiac Masses. JACC Cardiovasc Imaging. 2022 Nov;15(11):2010-2012.
• Armillotta M, Foà A, Pizzi C. Cardiac troponin elevation after coronary artery bypass graft: improving risk stratification. Eur Heart J. 2022 Oct 20:ehac537.
• Cesaro A, Gragnano F, Paolisso P, Bergamaschi L, Gallinoro E, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Oreglia JA, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Pizzi C, Barbato E, Calabrò P, Marfella R. In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-
  inhibitors: Insights from the SGLT2-I AMI PROTECT study. Front Cardiovasc Med. 2022 Sep 27;9:1012220.
• Angeli F, Fabrizio M, Paolisso P, Magnani I, Bergamaschi L, Bartoli L, Stefanizzi A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Tattilo FP, Suma N, Bodega F, Canton L, Rinaldi A, Foà A, Pizzi C. Classificazione, caratteristiche cliniche e strategie diagnostiche delle masse cardiache [Cardiac masses: classification, clinical features and diagnostic approach]. G Ital Cardiol (Rome).
  2022 Aug;23(8):620-630.
• Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovasc Diabetol. 2022 May 15;21(1):77.
• Paolisso P, Foà A, Bergamaschi L, Angeli F, Fabrizio M, Donati F, Toniolo S, Chiti C, Rinaldi A, Stefanizzi A, Armillotta M, Sansonetti A, Magnani I, Iannopollo G, Rucci P, Casella G, Galiè N, Pizzi C. Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA. Cardiovasc Diabetol. 2021 Sep 24;20(1):192.
• Paolisso P, Foà A, Bergamaschi L, Donati F, Fabrizio M, Chiti C, Angeli F, Toniolo S, Stefanizzi A, Armillotta M, Rucci P, Iannopollo G, Casella G, Marrozzini C, Galiè N, Pizzi C. Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA. Cardiovasc Diabetol. 2021 Feb 2;20(1):33.